menu
    • menu

    Company profile for Luye Pharma

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Luye Pharma Group, a member of Luye Life Sciences Group, is an international pharmaceutical company with a focus on targeting central nervous system (CNS), oncology, cardiovascular and other therapeutic areas. Global R&D, global manufacturing, and the global sale of innovative medications are the company’s three main strategic priorities. R&D centers in China, the U.S. and Europe with a robust pipeline of 30+ drug candidates...
    Luye Pharma Group, a member of Luye Life Sciences Group, is an international pharmaceutical company with a focus on targeting central nervous system (CNS), oncology, cardiovascular and other therapeutic areas. Global R&D, global manufacturing, and the global sale of innovative medications are the company’s three main strategic priorities. R&D centers in China, the U.S. and Europe with a robust pipeline of 30+ drug candidates in China and 10+ drug candidates overseas. A series of innovative antibody and biosimilar products are under development. Several new drugs and new formulations in CNS and Oncology therapeutic areas.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Luye PharmaChina Flag
    Country
    Country
    China
    Address
    Address
    22F, Gubei International Fortune Center II, Hongqiao Road 1438, Changning Dist...
    Telephone
    Telephone
    (86)21-6237-6350
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.luye.cn/lvye_en/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Luye Pharma Launches Erzofri in U.S. for Schizophrenia Treatment
    Luye Pharma Launches Erzofri in U.S. for Schizophrenia Treatment

    07 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/luye-pharma-announces-us-launch-of-erzofri-paliperidone-palmitate-extended-release-injectable-suspension-for-the-treatment-of-schizophrenia-and-schizoaffective-disorder-302421464.html

    PR NEWSWIRE
    07 Apr 2025
    Share Share
    FDA Approves Luye Pharma's ERZOFRI For Schizophrenia Treatment
    FDA Approves Luye Pharma's ERZOFRI For Schizophrenia Treatment

    28 Jul 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/luye-pharma-announces-us-fda-approval-of-erzofri-paliperidone-palmitate-extended-release-injectable-suspension-for-treating-schizophrenia-and-schizoaffective-disorder-302208155.html

    PR NEWSWIRE
    28 Jul 2024
    Share Share
    Luye Pharma Files NDA for Rivastigmine Patch in Japan for AD
    Luye Pharma Files NDA for Rivastigmine Patch in Japan for AD

    06 Jun 2024

    // PRESS RELEASE

    https://www.luye.cn/lvye_en/view.php?id=2250

    PRESS RELEASE
    06 Jun 2024
    Share Share
    Luye Pharma partners with Korea-based Myung In Pharm
    Luye Pharma partners with Korea-based Myung In Pharm

    07 Feb 2024

    // BIOSPECTRUM ASIA

    https://www.biospectrumasia.com/news/25/23688/chinas-luye-pharma-partners-with-korea-based-myung-in-pharm-to-improve-alzheimers-related-dementia-treatment.html

    BIOSPECTRUM ASIA
    07 Feb 2024
    Share Share
    Luye, Duopharma to expand accessibility of cholesterol management products
    Luye, Duopharma to expand accessibility of cholesterol management products

    05 Apr 2023

    // BIOSPECTRUM ASIA

    https://www.biospectrumasia.com/news/25/22232/luye-pharma-duopharma-to-expand-accessibility-of-cholesterol-management-products-in-malaysia.html

    BIOSPECTRUM ASIA
    05 Apr 2023
    Share Share
    US FDA approves Luye Pharma’s schizophrenia treatment Rykindo
    US FDA approves Luye Pharma’s schizophrenia treatment Rykindo

    16 Jan 2023

    // PHARMACEUTICAL TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/fda-schizophrenia-treatment-rykindo/

    PHARMACEUTICAL TECHNOLOGY
    16 Jan 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search